These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29307857)

  • 1. Role of regulatory T cells in irinotecan-induced intestinal mucositis.
    Fernandes C; Wanderley CWS; Silva CMS; Muniz HA; Teixeira MA; Souza NRP; Cândido AGF; Falcão RB; Souza MHLP; Almeida PRC; Câmara LMC; Lima-Júnior RCP
    Eur J Pharm Sci; 2018 Mar; 115():158-166. PubMed ID: 29307857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
    Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
    Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
    PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
    Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
    Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
    Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifidobacterium Infantis Ameliorates Chemotherapy-Induced Intestinal Mucositis Via Regulating T Cell Immunity in Colorectal Cancer Rats.
    Mi H; Dong Y; Zhang B; Wang H; Peter CCK; Gao P; Fu H; Gao Y
    Cell Physiol Biochem; 2017; 42(6):2330-2341. PubMed ID: 28848081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.
    Lima-Júnior RC; Freitas HC; Wong DV; Wanderley CW; Nunes LG; Leite LL; Miranda SP; Souza MH; Brito GA; Magalhães PJ; Teixeira MM; Cunha FQ; Ribeiro RA
    Br J Pharmacol; 2014 May; 171(9):2335-50. PubMed ID: 24428790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
    Alvarenga EM; Souza LK; Araújo TS; Nogueira KM; Sousa FB; Araújo AR; Martins CS; Pacífico DM; de C Brito GA; Souza EP; Sousa DP; Medeiros JV
    Chem Biol Interact; 2016 Dec; 260():129-140. PubMed ID: 27838229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
    Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
    Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice.
    Justino PF; Melo LF; Nogueira AF; Costa JV; Silva LM; Santos CM; Mendes WO; Costa MR; Franco AX; Lima AA; Ribeiro RA; Souza MH; Soares PM
    Br J Nutr; 2014 May; 111(9):1611-21. PubMed ID: 24503021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1β and IL-18 in mice.
    Arifa RD; Madeira MF; de Paula TP; Lima RL; Tavares LD; Menezes-Garcia Z; Fagundes CT; Rachid MA; Ryffel B; Zamboni DS; Teixeira MM; Souza DG
    Am J Pathol; 2014 Jul; 184(7):2023-34. PubMed ID: 24952429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect and potential mechanisms of Wei-Chang-An pill on high-dose 5-fluorouracil-induced intestinal mucositis in mice.
    Chen Y; Zheng H; Zhang J; Wang L; Jin Z; Gao W
    J Ethnopharmacol; 2016 Aug; 190():200-11. PubMed ID: 27240747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.
    Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
    Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.
    Ikuno N; Soda H; Watanabe M; Oka M
    J Natl Cancer Inst; 1995 Dec; 87(24):1876-83. PubMed ID: 7494232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses.
    Sang LX; Chang B; Zhu JF; Yang FL; Li Y; Jiang XF; Wang DN; Lu CL; Sun X
    World J Gastroenterol; 2017 Jun; 23(21):3850-3863. PubMed ID: 28638225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model.
    Ali J; Khan AU; Shah FA; Ali H; Islam SU; Kim YS; Khan S
    Life Sci; 2019 Dec; 239():116888. PubMed ID: 31639401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium.
    Shinohara H; Killion JJ; Bucana CD; Yano S; Fidler IJ
    Clin Cancer Res; 1999 Aug; 5(8):2148-56. PubMed ID: 10473099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.